Alcohol use disorder (AUD) is a major global public health issue, affecting more than 28 million adults in the United States ...

There is a connection between alcohol and anxiety the day after you drink for many reasons, even if you’ve not been diagnosed ...

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.

More than 60 percent of Vermont residents drink, a figure that’s nearly 10 percent higher than the U.S. average.

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

He also has untreated sleep apnea. He would like to try one of the GLP-1 drugs to lose some weight, but I am concerned about ...

My 66-year-old husband recently received a diagnosis of heart failure with preserved ejection fraction. He is 5 feet, 7 inches tall, and weighs 270 pounds. He is treating his fluid retention with 100 ...

Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.

Lawmakers are hoping to expand and improve upon a 2015 law that offers grants to county jails treating inmates experiencing substance use disorders. Act 80 provides funding for the use of naltrexone, ...